Scroll to top

News

CLINUVEL
Posted by CLINUVEL
June 10, 2021

CLINUVEL Kommuniqué III

Sehr geehrte Aktionärinnen und Aktionäre, liebe Freunde, EINFÜHRUNG Während des Lockdown hatte...

Read More
CLINUVEL
Posted by CLINUVEL
June 7, 2021

Media Release - First stroke patient treated with afamelanotide

Melbourne, Australia, 07 June 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
June 7, 2021

First stroke patient treated with afamelanotide

Melbourne, Australia, 07 June 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
June 4, 2021

CLINUVEL Presentation to Jefferies Healthcare Conference

Melbourne, Australia, 04 June 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
June 3, 2021

CLINUVEL Communiqué III

Dear shareholders, friends, INTRODUCTION During the lockdowns our team has had plenty...

Read More
CLINUVEL
Posted by CLINUVEL
June 1, 2021

Appendix 3Y Change of Director's Interest Notice

Information or documents not available now must be given to ASX as...

Read More
CLINUVEL
Posted by CLINUVEL
May 31, 2021

Chairman's Letter II

31 MAY 2021 Update during 2021 In a year with many ups...

Read More
CLINUVEL
Posted by CLINUVEL.
May 21, 2021
CLINUVEL
Posted by CLINUVEL
April 29, 2021

Appendix 4C & Activity Report

Melbourne, Australia, 29 April 2021 CLINUVEL PHARMACEUTICALS LTD today announced its Appendix...

Read More
CLINUVEL
Posted by CLINUVEL
April 26, 2021

Wilsons Initiates Research Coverage of CLINUVEL

Melbourne, Australia, 26 April 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
We use cookies to give you the best experience.